Colorectal Cancer Screening
Customize your policy alerts
Sign up for Blue Cross Blue Shield - New Mexico Policy RPLAB071 alerts
Get alerted when Policy RPLAB071 changes without checking for updates manually.
Monitor payer policy activity
Defines BCBSNM laboratory management reimbursement criteria for colorectal cancer screening tests and which screening modalities are reimbursable or excluded for asymptomatic individuals, affecting providers submitting claims to Blue Cross Blue Shield of New Mexico.
Added code 87626 and removed code 0500T in the 05/15/2026 update.
Previously (08/08/2025) reimbursement information was updated to add Cologuard Plus as reimbursable once every 3 years and to state cell-free DNA techniques (e.g., Guardant Shield) are not reimbursable.
Reimbursement Information unchanged in the 05/15/2026 update; document updated with literature review and minor code list changes.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.